Ryan Deasy, MD
Ophthalmology · Richmond, VANPI 1568418523
Payments from drug & device makers
Across 522 payments — averaging $35.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Notal Vision, Inc.$16K
- Regeneron Healthcare Solutions, Inc.$477
- Alimera Sciences, Inc.$434
- AbbVie$297
- Genentech USA, Inc.$289
- Glaukos Corporation$186
- plus $1K from 15 others
What the payments were for
- Speaking & faculty fees$38910%
- Food & beverage$3,47790%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Notal Vision, Inc. | 431 | $16,019 |
| Regeneron Healthcare Solutions, Inc. | 18 | $477 |
| Alimera Sciences, Inc. | 11 | $434 |
| AbbVie(2 entities) | 24 | $297 |
| Genentech USA, Inc. | 9 | $289 |
| Glaukos Corporation | 1 | $186 |
| Dutch Ophthalmic, USA | 1 | $177 |
| Harrow Eye, LLC | 6 | $150 |
| Alcon | 1 | $148 |
| Genentech, Inc. | 1 | $108 |
| Mallinckrodt Hospital Products Inc. | 3 | $102 |
| Bausch & Lomb Americas Inc. | 3 | $64 |
| Novartis | 3 | $62 |
| Astellas Pharma US Inc | 2 | $57 |
| Amgen(2 entities) | 2 | $45 |
| Coherus Oncology, Inc. | 1 | $32 |
| Apellis Pharmaceuticals, Inc. | 1 | $23 |
| Thea Pharma Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Eyepoint US, Inc. | 1 | $19 |
| Spark Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iluvien$246
- VABYSMO$234
- iDose$186
- EVA Ophthalmic Surgical System$177
- Centurion$148
How this compares
$18,746 in reported general payments places this provider in the 90th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 149 | $4,568 |
| Brimonidine Tartrate | 29 | $2,408 |
| MoxifloxacinMoxifloxacin Hcl | 48 | $1,418 |
| Ketorolac Tromethamine | 27 | $640 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 28 | $610 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 46 | $604 |
| Latanoprost | 28 | $295 |
| Timolol Maleate | 12 | $117 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Richmond
- Ali TabassianRichmond$2.1M
- Ethnie JonesRichmond$2M
- John O KeefeRichmond$44K
- Byron LaddRichmond$32K
- Thomas JenkinsRichmond$26K
- Jessica RandolphRichmond$18K
- David JacobsRichmond$16K
- Nikisha RichardsRichmond$16K
- Kenneth PriceRichmond$14K
- Tam DangRichmond$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.